Explore End-to-End CMC Solutions with Frontage

​​​​​​At Frontage Laboratories, we bring over 25+ years of proven expertise in drug development, offering integrated end-to-end CMC solutions to accelerate your path from discovery to market.

Drug Product Development & Manufacturing

• Sterile Dosage Forms: Injectables and PFS – Aseptic processing for small and large molecules in ISO-qualified cleanrooms with semi- and fully automated sterile filling lines.
• Non-Sterile Dosage Forms: Expertise in tablets, capsules, oral liquids, semisolids, Ophthalmics, from early development through commercialization.
• Specialized handling of high-potency compounds (down to OEL <1 µg/m³, OEB 1-5) and DEA-licensed manufacturing (Schedules I–V).
• Strong Analytical Expertise: Method Development, Method Validations, Extractable & Leachable, Nitrosamine, Bioburden and Sterility Testing, Dissolution, IVRT/IVPT, all USP/EP monographs
• Support NDA, 505(b)(2), ANDA, BLA

Regulatory & Quality Excellence

• Inspected and approved by US FDA, EU QP & routine client audits.
• Strong Quality Assurance systems with a track record of global compliance.

Why Partner with Frontage?

• US based company, Headquarters at Exton, Pennsylvania
• Global experience in navigating drug substance and product complexities.
• Flexible, customized solutions designed to fit your development pipeline.
• Collaborative and responsive approach trusted by innovators and generics alike.

Frontage Laboratories – Your Partner in Accelerating CMC Development from Bench to Clinic and all the way to commercialization.

Meet Our Team

John Stradling Director, Business Development

Srikanth Manne Director, Scientific Strategy & Business Development

Visit Event Website

Schedule a Meeting: